🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

RecruitingNAAges 18 Years - anyAllChanghai Hospital
NCT06728826 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients older than or equal to 18 years of age * Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries * Able to provide informed consent Exclusion Criteria: * History of atrial fibrillation or flutter * Reoperations/minimally invasive cardiac surgery/emergent presentation * Need for hypothermic circulatory arrest * Disease of the left pleura or previous left thoracotomy * Chest deformity * Unlikely to participate in follow-up assessments
💊

What it tests

  • Posterior pericardiotomy
📍

Where

1 site
Changhai Hospital
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy